Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (311-320 of 381) with videos related to

Pageof 39
Sort By:
Critical Reviews in Oncology/Hematology|March 9, 2024
Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysisFernando Sabino Marques Monteiro, Andrey Soares, Veronica Mollica, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 13, 2020
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experienceGiovanni Brandi, Alessandro Rizzo, Filippo Gustavo Dall'Olio, et al.
Digital Health|February 2, 2026
Enhancing early prediction of pathological complete response in breast cancer using attention-based convolutional neural networks in digital pathologyMaria Colomba Comes, Andrea Lupo, Arianna Bozzi, et al.
Scientific Reports|November 23, 2023
Comparison between vision transformers and convolutional neural networks to predict non-small lung cancer recurrenceAnnarita Fanizzi, Federico Fadda, Maria Colomba Comes, et al.
La Radiologia Medica|May 17, 2023
Impact of the systematic introduction of tomosynthesis on breast biopsies: 10 years of resultsDaniele La Forgia, Rahel Signorile, Samantha Bove, et al.
Targeted Oncology|December 11, 2021
Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell CarcinomaVeronica Mollica, Matteo Santoni, Marc R Matrana, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 28, 2022
Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatmentRaffaele De Luca, Luca Gianotti, Paolo Pedrazzoli, et al.
European Urology Focus|February 23, 2022
Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase InhibitorsMatteo Santoni, Francesco Massari, Sergio Bracarda, et al.
Expert Review of Clinical Pharmacology|November 13, 2025
Immunotherapy in biliary tract cancer: effective but not enough?Alessandro Rizzo, Enes Erul, Deniz Can Guven, et al.
Scientific Reports|February 7, 2024
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapiesGiovanni Brandi, Valeria Relli, Marzia Deserti, et al.
Pageof 39

Showing results (311-320 of 381) with videos related to

Sort By:
Pageof 39
Critical Reviews in Oncology/Hematology|March 9, 2024
Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysisFernando Sabino Marques Monteiro, Andrey Soares, Veronica Mollica, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 13, 2020
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experienceGiovanni Brandi, Alessandro Rizzo, Filippo Gustavo Dall'Olio, et al.
Digital Health|February 2, 2026
Enhancing early prediction of pathological complete response in breast cancer using attention-based convolutional neural networks in digital pathologyMaria Colomba Comes, Andrea Lupo, Arianna Bozzi, et al.
Scientific Reports|November 23, 2023
Comparison between vision transformers and convolutional neural networks to predict non-small lung cancer recurrenceAnnarita Fanizzi, Federico Fadda, Maria Colomba Comes, et al.
La Radiologia Medica|May 17, 2023
Impact of the systematic introduction of tomosynthesis on breast biopsies: 10 years of resultsDaniele La Forgia, Rahel Signorile, Samantha Bove, et al.
Targeted Oncology|December 11, 2021
Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell CarcinomaVeronica Mollica, Matteo Santoni, Marc R Matrana, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 28, 2022
Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatmentRaffaele De Luca, Luca Gianotti, Paolo Pedrazzoli, et al.
European Urology Focus|February 23, 2022
Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase InhibitorsMatteo Santoni, Francesco Massari, Sergio Bracarda, et al.
Expert Review of Clinical Pharmacology|November 13, 2025
Immunotherapy in biliary tract cancer: effective but not enough?Alessandro Rizzo, Enes Erul, Deniz Can Guven, et al.
Scientific Reports|February 7, 2024
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapiesGiovanni Brandi, Valeria Relli, Marzia Deserti, et al.
Pageof 39